Home > Qtrly Results > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Quarterly Results Analysis [Sep2024]

GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Results

Consolidated Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Revenues ₹1,011 Cr ₹815 Cr ₹930 Cr ₹805 Cr ₹957 Cr ₹762 Cr ₹787 Cr ₹802 Cr
Expenses ₹689 Cr ₹584 Cr ₹673 Cr ₹587 Cr ₹668 Cr ₹618 Cr ₹618 Cr ₹574 Cr
Operating Income ₹322 Cr ₹231 Cr ₹257 Cr ₹218 Cr ₹289 Cr ₹144 Cr ₹170 Cr ₹229 Cr
Other Income ₹35 Cr ₹36 Cr ₹30 Cr ₹28 Cr ₹28 Cr ₹36 Cr ₹28 Cr ₹23 Cr
Interest ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr
Depreciation ₹17 Cr ₹16 Cr ₹18 Cr ₹17 Cr ₹18 Cr ₹16 Cr ₹17 Cr ₹16 Cr
Profit Before Tax ₹344 Cr ₹249 Cr ₹271 Cr ₹65 Cr ₹299 Cr ₹181 Cr ₹190 Cr ₹224 Cr
Profit After Tax ₹253 Cr ₹182 Cr ₹194 Cr ₹46 Cr ₹218 Cr ₹132 Cr ₹133 Cr ₹165 Cr
EPS ₹14.90 ₹10.76 ₹11.48 ₹2.70 ₹12.84 ₹7.81 ₹7.88 ₹9.71
Industry Peers & Returns1W1M1Y
GLAXOSMITHKLINE PHARMACEUTICALS -3% -3.4% 35.3%
SUN PHARMACEUTICAL INDUSTRIES 1% 0.7% 47.3%
CIPLA 0.3% -1.8% 19.6%
DR REDDYS LABORATORIES 6% 11.8% 20.3%
ZYDUS LIFESCIENCES -1.5% -0.1% 47%
DIVIS LABORATORIES -1.1% -5.8% 61.7%
MANKIND PHARMA 3.7% 11.4% 59.4%
TORRENT PHARMACEUTICALS 0.6% 4.1% 59.5%
LUPIN 3.3% 2.9% 75.9%

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

24.07 %

Y-o-Y

5.62 %

Quarters Revenues % Change
Sep2024 ₹1,011 Cr
24.07
Jun2024 ₹815 Cr
-12.38
Mar2024 ₹930 Cr
15.47
Dec2023 ₹805 Cr
-15.85
Sep2023 ₹957 Cr
25.65
Jun2023 ₹762 Cr
-3.28
Mar2023 ₹787 Cr
-1.85
Dec2022 ₹802 Cr -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

39.55 %

Y-o-Y

11.13 %

Quarters Operating Profit % Change
Sep2024 ₹322 Cr
39.55
Jun2024 ₹231 Cr
-10.39
Mar2024 ₹257 Cr
17.98
Dec2023 ₹218 Cr
-24.67
Sep2023 ₹289 Cr
101.20
Jun2023 ₹144 Cr
-15.24
Mar2023 ₹170 Cr
-25.78
Dec2022 ₹229 Cr -
Operating Margins
Q-o-Q

12.47 %

Y-o-Y

5.22 %

Quarters Operating Margin% % Change
Sep2024 31.83%
12.47
Jun2024 28.3%
2.28
Mar2024 27.67%
2.18
Dec2023 27.08%
-10.48
Sep2023 30.25%
60.14
Jun2023 18.89%
-12.38
Mar2023 21.56%
-24.38
Dec2022 28.51% -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

38.49 %

Y-o-Y

16.09 %

Quarters Profit After Tax % Change
Sep2024 ₹253 Cr
38.49
Jun2024 ₹182 Cr
-6.25
Mar2024 ₹194 Cr
325.37
Dec2023 ₹46 Cr
-78.98
Sep2023 ₹218 Cr
64.47
Jun2023 ₹132 Cr
-0.88
Mar2023 ₹133 Cr
-18.92
Dec2022 ₹165 Cr -
PAT Margins
Q-o-Q

11.62 %

Y-o-Y

9.90 %

Quarters PAT Margin(%) % Change
Sep2024 24.98 %
11.62
Jun2024 22.38 %
6.98
Mar2024 20.92 %
268.31
Dec2023 5.68 %
-75.01
Sep2023 22.73 %
30.93
Jun2023 17.36 %
2.48
Mar2023 16.94 %
-17.41
Dec2022 20.51 % -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

38.48 %

Y-o-Y

16.04 %

Quarters EPS % Change
Sep2024 ₹14.9
38.48
Jun2024 ₹10.76
-6.27
Mar2024 ₹11.48
325.19
Dec2023 ₹2.7
-78.97
Sep2023 ₹12.84
64.40
Jun2023 ₹7.81
-0.89
Mar2023 ₹7.88
-18.85
Dec2022 ₹9.71 -

You may also like the below Video Courses